Related Experiment Video
Updated: May 14, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Demand-side policies to encourage the use of generic medicines: an overview
Pieter Dylst1, Arnold Vulto, Steven Simoens
1Department of Pharmaceutical & Pharmacological Sciences, KU Leuven, Herestraat 49, O&N 2, PO Box 521, 3000 Leuven, Belgium. pieter.dylst@pharm.kuleuven.be
Abstract:
Demand-side policies to encourage the use of generic medicines are important to increase their use. A plethora of different demand-side policies has already been initiated by European governments, thereby targeting physicians, pharmacists and patients. This review aims to give an overview of the different demand-side policies which governments have at their disposal and to evaluate their impact on the use of generic medicines. Positive knowledge and perceptions of physicians, pharmacists and patients of generic medicines are necessary prerequisites to increase the use of generic medicines and governments should initiate policies to achieve this. These policies should be combined with policies to increase their financial responsibility to the healthcare system and policies to facilitate the prescribing of generic medicines.
More Related Videos
06:26Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Nomenclature
Drug Products: Biologics, Biosimilars and Interchangeables
Dosage Regimen: Individualization
Bioequivalence of Drugs: Drugs with Multiple Indications
Drug Regulation